Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma

  1. Suvannasankha, A.
  2. Bahlis, N.
  3. Trudel, S.
  4. Weisel, K.
  5. Koenecke, C.
  6. Oriol, A.
  7. Voorhees, P.M.
  8. Alonso, A.A.
  9. Callander, N.S.
  10. Mateos, M.-V.
  11. Reddy, N.
  12. Hakim, S.
  13. LaMacchia, J.
  14. Patel, N.
  15. Williams, D.
  16. Jewell, R.C.
  17. Zhou, X.
  18. Gupta, I.
  19. Opalinska, J.
  20. Nooka, A.K.
Aldizkaria:
Cancer

ISSN: 1097-0142,  0008-543X

Argitalpen urtea: 2024

Mota: Artikulua

DOI: 10.1002/CNCR.35319 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus